If you have PCOS and are struggling with weight or insulin resistance, a GLP-1 may be worth discussing with your provider
Because tissue repair involves coordinated migration of cells, deposition of new matrix, angiogenesis, and resolution of inflammation, the peptides multifaceted support for matrix biology positions it as a candidate molecule for research in organ repair, scaffold design, and regenerative scaffolding strategies
The result is a targeted boost for your immune system, hydration, and overall wellnesswithout stimulants, sugars, or gastrointestinal discomfort
Here is a summary of the data for Utah : Share of all patients who take a GLP-1: 0.7% Share of patients with an obesity diagnosis who take a GLP-1: 4.8% Share of male patients with an obesity diagnosis who take a GLP-1: 4.4% Share of female patients with an obesity diagnosis who take a GLP-1: 5.1% Share of GLP-1 users that are female: 60.4% For reference, here are the statistics for the entire United States: Share of all patients who take a GLP-1: 1.0% Share of patients with an obesity diagnosis who take a GLP-1: 4.8% Share of male patients with an obesity diagnosis who take a GLP-1: 4.2% Share of female patients with an obesity diagnosis who take a GLP-1: 5.2% Share of GLP-1 users that are female: 64.7% For more information, a detailed methodology, and complete results, see U.S
doi: 10.1515/CCLM.2011.059, PMID: [DOI] [PubMed] [Google Scholar] 25.Li JM, Li LY, Qin X, Ning LJ, Lu DL, Li DL, et al
